Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS medicine 15 (7), e1002591, 2018 | 145 | 2018 |
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ... The lancet respiratory medicine 6 (4), 265-275, 2018 | 104 | 2018 |
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges M Tadolini, AJ Garcia-Prats, L D'Ambrosio, C Hewison, R Centis, ... European Respiratory Journal 48 (3), 938-943, 2016 | 92 | 2016 |
Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro C Yang, ZW Gu, M Yang, SN Lin, AJ Garcia-Prats, LK Rogers, SE Welty, ... Journal of lipid research 40 (4), 686-698, 1999 | 91 | 1999 |
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? A Reuter, P Tisile, D Von Delft, H Cox, V Cox, L Ditiu, A Garcia-Prats, ... The International Journal of Tuberculosis and Lung Disease 21 (11), 1114-1126, 2017 | 90 | 2017 |
Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis S Thee, AJ Garcia-Prats, HR Draper, HM McIlleron, L Wiesner, S Castel, ... Clinical Infectious Diseases 60 (4), 549-556, 2015 | 86 | 2015 |
New and repurposed drugs for pediatric multidrug-resistant tuberculosis. Practice-based recommendations EP Harausz, AJ Garcia-Prats, JA Seddon, HS Schaaf, AC Hesseling, ... American journal of respiratory and critical care medicine 195 (10), 1300-1310, 2017 | 82 | 2017 |
A review of the use of ethionamide and prothionamide in childhood tuberculosis S Thee, AJ Garcia-Prats, PR Donald, AC Hesseling, HS Schaaf Tuberculosis 97, 126-136, 2016 | 72 | 2016 |
Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations AJ Garcia-Prats, PC Rose, AC Hesseling, HS Schaaf Tuberculosis 94 (2), 93-104, 2014 | 66 | 2014 |
Fluoroquinolones for the treatment of tuberculosis in children S Thee, AJ Garcia-Prats, PR Donald, AC Hesseling, HS Schaaf Tuberculosis 95 (3), 229-245, 2015 | 65 | 2015 |
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children S Thee, AJ Garcia-Prats, HM McIlleron, L Wiesner, S Castel, J Norman, ... Antimicrobial agents and chemotherapy 58 (5), 2948-2951, 2014 | 63 | 2014 |
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised … JA Seddon, AJ Garcia-Prats, SE Purchase, M Osman, AM Demers, ... Trials 19, 1-11, 2018 | 53 | 2018 |
Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis P Denti, AJ Garcia-Prats, HR Draper, L Wiesner, J Winckler, S Thee, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 01521-17, 2018 | 51 | 2018 |
Clinical standards for the dosing and management of TB drugs JWC Alffenaar, SL Stocker, LD Forsman, A Garcia-Prats, SK Heysell, ... The International Journal of Tuberculosis and Lung Disease 26 (6), 483-499, 2022 | 49 | 2022 |
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: combined data from two prospective observational studies AJ Garcia-Prats, HS Schaaf, HR Draper, M Garcia-Cremades, J Winckler, ... PLoS medicine 16 (4), e1002789, 2019 | 46 | 2019 |
Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children AJ Garcia-Prats, EM Svensson, ED Weld, HS Schaaf, AC Hesseling The International Journal of Tuberculosis and Lung Disease 22 (5), S15-S23, 2018 | 40 | 2018 |
Inclusion of key populations in clinical trials of new antituberculosis treatments: current barriers and recommendations for pregnant and lactating women, children, and HIV … A Gupta, MD Hughes, AJ Garcia-Prats, K McIntire, AC Hesseling PLoS medicine 16 (8), e1002882, 2019 | 39 | 2019 |
Adverse effects of oral second-line antituberculosis drugs in children HS Schaaf, S Thee, L van der Laan, AC Hesseling, AJ Garcia-Prats Expert opinion on drug safety 15 (10), 1369-1381, 2016 | 38 | 2016 |
Managing multidrug-resistant tuberculosis in children: review of recent developments HS Schaaf, AJ Garcia-Prats, AC Hesseling, JA Seddon Current opinion in infectious diseases 27 (3), 211-219, 2014 | 38 | 2014 |
Relative bioavailability of bedaquiline tablets suspended in water: implications for dosing in children EM Svensson, J du Bois, R Kitshoff, VR de Jager, L Wiesner, J Norman, ... British Journal of Clinical Pharmacology 84 (10), 2384-2392, 2018 | 37 | 2018 |